Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous Close | 193.07 |
| Open | 194.43 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1100 |
| Day's Range | 187.58 - 195.00 |
| 52 Week Range | 115.03 - 217.25 |
| Volume | |
| Avg. Volume | 5,228,038 |
| Market Cap | 78.349B |
| Beta (5Y Monthly) | 1.69 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.96 |
| Earnings Date | Feb 22, 2023 - Feb 27, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 207.29 |
- Zacks
Moderna (MRNA) Gains But Lags Market: What You Should Know
Moderna (MRNA) closed the most recent trading day at $193.24, moving +0.09% from the previous trading session.
- Motley Fool
2 Top Biotech Stocks to Buy for the Long Haul
Equity markets are entirely unpredictable in the short run. The biotech industry is a great place to look for stocks that can survive down markets and be successful over long periods since the drugs these companies develop are so critical to their customers' lives. Let's look at two biotech stocks to buy today and hold on to for a while: Amgen (NASDAQ: AMGN) and Moderna (NASDAQ: MRNA).
- Zacks
Novavax (NVAX) COVID Jab Aids Growth, Overdependence A Woe
Despite being one of the few authorized COVID-19 vaccine makers in the United States, Novavax's (NVAX) vaccine struggles for market share.
© 2023 Yahoo. All rights reserved.
